Azasite

Merck to pay $5.9 mln for misleading marketing of pink eye drug: U.S.
Yahoo/Reuters
Wed, 06/17/15 - 04:58 pm
Merck
pink eye
Inspire
Azasite
Akorn Acquires U.S. Rights to Trio of Merck Eye Treatments
Motley Fool
Sat, 11/16/13 - 01:33 pm
Akorn
Merck
Azasite
Cosopt
Cosopt PF
Merck, Pfizer Sue Mylan to Block Proposed Copy of AzaSite
Bloomberg
Mon, 06/17/13 - 12:50 pm
Pfizer
Merck
Mylan
Azasite
generics
2 Risks Facing Merck Today
Motley Fool
Mon, 11/12/12 - 11:26 am
Merck
Vioxx
Azasite
Cancidas
Nasonex
Nexium
Noxafil
Vytorin
Zetia
Emend
generics
Merck, InSite Vision amend payment terms of AzaSite license agreement
Yahoo/Fly on the Wall
Mon, 08/13/12 - 12:03 pm
Merck
InSite Vision
Azasite
Justice subpoenas Merck on drug marketing
Fierce Pharma
Thu, 11/10/11 - 01:19 pm
Merck
subpoena
Integrilin
Avelox
Azasite
Inspire's Pink Eye Drug AzaSite Draws Generic Challenge
Motley Fool
Wed, 04/27/11 - 11:31 am
Inspire
generics
Azasite
Merck
pink eye
Inspire Pharmaceuticals' eye drug Azasite fails to meet key goals in midstage studies
Yahoo/AP
Mon, 03/15/10 - 11:50 am
Inspire
Azasite
Inspire posts smaller loss as Azasite sales rise
Yahoo/AP
Thu, 03/4/10 - 09:41 am
Inspire
earnings
Azasite